Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Boosting the immunotherapy response by nutritional interventions
Laurence Zitvogel, Guido Kroemer
Laurence Zitvogel, Guido Kroemer
Published June 1, 2022
Citation Information: J Clin Invest. 2022;132(11):e161483. https://doi.org/10.1172/JCI161483.
View: Text | PDF
Viewpoint

Boosting the immunotherapy response by nutritional interventions

  • Text
  • PDF
Abstract

Authors

Laurence Zitvogel, Guido Kroemer

×

Figure 1

Dietary interventions for sensitizing to ICIs targeting PD-1/PD-L1.

Options: View larger image (or click on image) Download as PowerPoint
Dietary interventions for sensitizing to ICIs targeting PD-1/PD-L1.
(A) ...
(A) Mechanisms of fasting-induced immunostimulation. Fasting causes a reduction of circulating IGF1 levels, which stimulates autophagy in cancer cells. (B) Ketogenic diet and its effects on the patient. Increased levels of the ketone body β-hydroxybutyrate stimulate GPR109A receptors expressed by immune cells and modify the gut microbiota (C) Supplementation with camu-camu–derived castalagin. In the intestinal lumen, castalagin directly acts on specific Ruminococcus species to stimulate their expansion. Some bacterial species, including Ruminococcus species, metabolize castalagin into urolithins, which might have immunostimulatory effects as well. All three dietary interventions modify the tumor microenvironment, hence enhancing the CD8/FOXP3 ratio in the immune infiltrate and sensitizing to immune checkpoint inhibition targeting the PD-1/PD-L1 interaction.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts